Is physostigmine effective for cardiac toxicity of tricyclic antidepressant drugs. 1977

J T Bigger, and S J Kantor, and A H Glassman, and J M Perel

UI MeSH Term Description Entries
D010830 Physostigmine A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity. Eserine
D005260 Female Females
D006329 Heart Conduction System An impulse-conducting system composed of modified cardiac muscle, having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart. Conduction System, Heart,Conduction Systems, Heart,Heart Conduction Systems,System, Heart Conduction,Systems, Heart Conduction
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000929 Antidepressive Agents, Tricyclic Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. Antidepressants, Tricyclic,Tricyclic Antidepressant,Tricyclic Antidepressant Drug,Tricyclic Antidepressive Agent,Tricyclic Antidepressive Agents,Antidepressant Drugs, Tricyclic,Agent, Tricyclic Antidepressive,Agents, Tricyclic Antidepressive,Antidepressant Drug, Tricyclic,Antidepressant, Tricyclic,Antidepressive Agent, Tricyclic,Drug, Tricyclic Antidepressant,Drugs, Tricyclic Antidepressant,Tricyclic Antidepressant Drugs,Tricyclic Antidepressants
D001145 Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac

Related Publications

J T Bigger, and S J Kantor, and A H Glassman, and J M Perel
June 1980, The Medical letter on drugs and therapeutics,
J T Bigger, and S J Kantor, and A H Glassman, and J M Perel
January 1977, Clinical toxicology,
J T Bigger, and S J Kantor, and A H Glassman, and J M Perel
November 1974, The American journal of psychiatry,
J T Bigger, and S J Kantor, and A H Glassman, and J M Perel
March 2008, Pediatric emergency care,
J T Bigger, and S J Kantor, and A H Glassman, and J M Perel
June 1976, JACEP,
J T Bigger, and S J Kantor, and A H Glassman, and J M Perel
October 1976, The British journal of psychiatry : the journal of mental science,
J T Bigger, and S J Kantor, and A H Glassman, and J M Perel
August 1977, The Journal of nervous and mental disease,
J T Bigger, and S J Kantor, and A H Glassman, and J M Perel
May 1976, Anaesthesia and intensive care,
J T Bigger, and S J Kantor, and A H Glassman, and J M Perel
September 1971, Clinical toxicology,
J T Bigger, and S J Kantor, and A H Glassman, and J M Perel
January 1977, Clinical toxicology,
Copied contents to your clipboard!